(Q45181387)

10 December 2017

title

Molecular genetic characterization of tamoxifen-associated endometrial cancer (English)

1 reference

10 December 2017

1 reference

4

Richard R Barakat

1 reference

10 December 2017

Monica Prasad

1

1 reference

10 December 2017

Hong Wang

series ordinal

2

1 reference

10 December 2017

Wayne Douglas

series ordinal

3

1 reference

10 December 2017

Lora Hedrick Ellenson

series ordinal

5

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

10 December 2017

1 reference

10 December 2017

volume

96

1 reference

10 December 2017

issue

1

1 reference

10 December 2017

page(s)

25-31

1 reference

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Risk of endometrial cancer after tamoxifen treatment of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

7 January 2021

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Association of tamoxifen and uterine sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Mutational Analysis of thePTENGene in Endometrial Carcinoma and Hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

PTEN1 is frequently mutated in primary endometrial carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Two cell lines established from mixed Müllerian tumors of the uterus morphologic, immunocytochemical, and cytogenetic analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Characteristics of cloned cells of mixed müllerian tumor of the human uterus carcinoma cells showing myogenic differentiation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Uterine carcinosarcoma is derived from a single stem cell: an in vitro study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Endometrial "sarcomas" complicating ovarian thecoma, polycystic ovarian disease and estrogen therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Mutations of the beta-catenin gene in endometrial carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Estrogen receptor-mediated effects of tamoxifen on human endometrial cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

Molecular determinants for the tissue specificity of SERMs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.046

10.1016/J.YGYNO.2004.08.046

7 January 2021

Identifiers

DOI

1 reference

10 December 2017

1 reference